Records containing: Multiple Sclerosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-02-04An Observational Study to Evaluate Immune Response to Covid-19 Vaccines, Infections and Immune Treatments in People With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2025-02-03A Double-blind, Crossover, Placebo-controlled Study to Compare the Effects of Nighttime Administration of Suvorexant in Patients With Multiple Sclerosis Fatigue and Insomnia
-
CLINICAL_TRIALS study record update · 2025-01-31The Effect of a Targeted Exercise Program on Balance and Postural Responses in Patients With Multiple Sclerosis (MS)
-
CLINICAL_TRIALS study record update · 2025-01-30Effectiveness of a Digital Health Application for Multiple Sclerosis (Levidex): Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2025-01-24Relıabılıty and valıdıty of the supıne-to-stand Test as a Measure of Functional Motor Competence ın People wıth Multiple Sclerosis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-01-24Efficacy of a Telehealth Pain Self-Management Intervention in Employed Adults With Physical Disability: A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2025-01-23A Phase I First in Human, Randomized, Double-blind, Placebo- Controlled Study in Healthy Adult Volunteers to Evaluate Safety, Tolerability and Pharmacokinetics of LPX-TI641 After Single and Multiple Oral Doses.
-
CLINICAL_TRIALS study record update · 2025-01-22A Phase 3b, Multicenter, Open-label Study to Evaluate the Immune Response to, and the Safety of, Vaccines in Participants With Relapsing Forms of Multiple Sclerosis Who Receive Oral Ozanimod Compared to Non-pegylated Interferon (IFN)-β or No Disease Modifying Therapy
-
CLINICAL_TRIALS study record update · 2025-01-22Natalizumab in Preventing Post-partum Relapses in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2025-01-22A 2-year Extension Study to Evaluate Long-term Effectiveness of Mavenclad® in Participants Who Have Completed Trial MS700568_0022 (MAGNIFY MS) (Magnify MS Extension)
-
CLINICAL_TRIALS study record update · 2025-01-22The Multi-National Gilenya Pregnancy Exposure Registry in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2025-01-15Effect of Cladribine Treatment on Microglial Activation in the CNS
-
CLINICAL_TRIALS study record update · 2025-01-15Multidimensional Integrated Assessment of Neurological and Immunological Patterns to Test the Efficacy and Response to Ozanimod in Multiple Sclerosis.
-
CLINICAL_TRIALS study record update · 2025-01-15Multimodal Imaging of MS Reveals the Smoldering Inflammation
-
CLINICAL_TRIALS study record update · 2025-01-14Post-Authorization Safety Study for Assessment of Pregnancy and Infant Outcomes in Patients Treated With Kesimpta (Ofatumumab) Using OTIS Observational Pregnancy Surveillance Program and DMSKW Registry
-
CLINICAL_TRIALS study record update · 2025-01-14Stem Cells in Rapidly Evolving Active Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2025-01-13KYSA-7: A Phase 2, Open-Label, Randomized, Multicenter Study of KYV-101, an Autologous Fully Human Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Primary and Secondary Progressive Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2025-01-09Pilot Study for the Evaluation of the More Stamina Mobile Application for Fatigue Management in Persons With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2025-01-07Exploratory Study of Entire-body PET Scans for Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2025-01-01An Exploratory Study on the Safety and Efficacy of Universal CAR-T Cells Targeting BCMA and CD19 in the Treatment of Refractory Autoimmune Diseases of the Nervous System
-
CLINICAL_TRIALS study record update · 2024-12-30A Retrospective Study on the Role of Short-chain Fatty Acids Modulation in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2024-12-27Sustainability of Exercise Therapy by the Use of Exercise Booster Sessions in People With Multiple Sclerosis.
-
CLINICAL_TRIALS study record update · 2024-12-27Anakinra for the Treatment of Chronically Inflamed White Matter Lesions in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2024-12-24Functional Electrical Stimulation Cycling for Managing Mobility Disability in People with Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2024-12-24Prospective Cohort Study of CLinical and Imaging Patterns of NeUroinflammation DisEases (CLUE)